Skip to content

Mobile App for Heart Failure

Self-Monitoring Using Mobile App for Reduction of Rehospitalization and Mortality in Heart Failure (SMART-HF)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05668000
Enrollment
84
Registered
2022-12-29
Start date
2022-10-19
Completion date
2023-01-26
Last updated
2023-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The investigators developed a mobile health platform to self-management in HF. The aim of this study is to evaluate whether this smartphone app-based intervention can improve symptoms of HF when compared to usual care in HF patients.

Interventions

OTHERBluetooth-connected monitoring devices and a feedback system

AIDA/KT-app with devices and feedback: The mobile application provide self-management interventions with devices including sphygomanometer and body water meter and a feedback system

OTHERMobile application

The mobile application provide only self-management interventions.

Sponsors

KT Corporation
CollaboratorINDUSTRY
Seoul National University Bundang Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 20 years or older hospitalized for acute heart failure. * Patients who have obvious symptoms or sign of HF at admission * N-terminal prohormone of brain natriuretic peptide (NT-proBNP) ≥400 pg/mL or brain natriuretic peptide (BNP) ≥100 pg/mL. * participants should be able to use smartphone well.

Exclusion criteria

* Patients who have baseline systolic blood pressure \<90 mmHg or resting heart rate \<50 beats per minutes * Patients who cannot use smartphone * Patients who had cardiac implantable electronic device will be excluded

Design outcomes

Primary

MeasureTime frameDescription
HF symptom by application scores.4 weeksthe mean value of scores of dyspnea, fatigue, and ankle edema stored in app by participants will be evaluated. Range 0(no symptom) - 3(severe symptom)
HF symptom by questionnaire4 weeksThe degree of dyspnea will be evaluated by questionnaire. Range: 0(worst)-10(best)

Secondary

MeasureTime frameDescription
Composite outcome4 weeksincluding death, rehospitalization, and unscheduled HF visit
Application satisfaction score4 weeksThe satisfaction score will be evaluated by questionnaire. Range: 0(worst)-10(best)
change in body water composition f4 weeksthe change in body water composition from baseline to the last measurement in the intervention group

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026